Information:
Fel:
Nyckelord
Ejaculatio Praecox ×
- Clinical Trial (44)
- Vital Signs (6)
- Drug trial (6)
- Electrocardiogram (ECG) (6)
- Liver (6)
- Urology (5)
- Adverse event (5)
- Drugs, Investigational (4)
- Compliance (4)
- Eligibility Determination (4)
- Laboratories (4)
- Pharmacokinetics (3)
- Supine Position (3)
- Pharmacogenetics (2)
- Pregnancy (2)
- Condoms (2)
- Concomitant Medication (2)
- End of Study (2)
- Disease Status (2)
- Demography (2)
- Alcohol Drinking (2)
- Eye (2)
- Follow-Up Studies (2)
- Random Allocation (1)
- Surgical Procedures, Operative (1)
- Biopsy (1)
- Blood (1)
- Sexuality (1)
- Trial screening (1)
- Non-operative therapeutic procedures (1)
- Circumcision, Male (1)
- Diagnostic Imaging (1)
- Double-Blind Method (1)
- Pharmaceutical Preparations (1)
- Liver Function Tests (1)
- Medical History Taking (1)
- Office Visits (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
44 Sökresultat.
Item-grupper: Liver Dysfunction or Failure by Clinical Classification Adverse Event, Serious Adverse Event, Liver Dysfunction or Failure by Clinical Classification Adverse Event, Notifications, Liver function, Laboratory procedures, Medical History, Experimental Drug, Liver
Item-grupper: Date of visit, Assessment Date, Adverse Event; Concomitant Agent; Evaluation, Repeat, Liver, Adverse Event, Non-serious Adverse Event, Serious Adverse Event, Concomitant Agent, Laboratory Procedures, Urinalysis, Vital signs, 12 lead ECG, 12 lead ECG, Abnormality, Repeat, Pharmacokinetic aspect, Blood, Repeat
Item-grupper: Inclusion, Exclusion Criteria, Medical History, Disease, Laboratory test result abnormal, Exclusion Criteria, other
Item-grupper: Date of visit, Vital signs, 12 lead ECG, Laboratory Procedures, Hematology finding, Laboratory Procedures, Chemistry, Clinical, Laboratory Procedures, Urinalysis, Laboratory Procedures, Hormones, Laboratory Procedures, Free Testosterone Measurement, Laboratory Procedures, Prolactin measurement, Nervous system structure, Evaluation, Ophthalmic examination and evaluation, Blinded Clinical Study, Status, Pregnancy, Information, Conclusion, Clinical Research
Item-grupper: Date of visit, Randomization, Numbers, Experimental drug, Vital signs, 12 lead ECG, Laboratory Procedures, Hematology finding, Laboratory Procedures, Chemistry, Clinical, Laboratory Procedures, Urinalysis, Laboratory Procedures, Hormones, Laboratory Procedures, Free Testosterone Measurement, Laboratory Procedures, Prolactin measurement, Pharmacokinetic aspects, Blood, Nervous system structure, Evaluation, Ejaculation, Response Latency, Time, Intravaginal
Item-grupper: Screening procedure, Enrollment, Date of visit, Demography, Eligibility Determination, Inclusion, Exclusion Criteria, Clinical Trial Subject Unique Identifier, Vital signs, 12 lead ECG, Laboratory Procedures, Hematology finding, Laboratory Procedures, Chemistry, Clinical, Laboratory Procedures, Urinalysis, Laboratory Procedures, Hormones, Laboratory Procedures, Free Testosterone Measurement, Laboratory Procedures, Prolactin measurement, Nervous system structure, Evaluation, Ophthalmic examination and evaluation, Ejaculation, Response Latency, Time, Intravaginal
Item-grupper: Date of visit, Liver, Adverse Event, Liver, Adverse Event, Experimental drug, Liver, Adverse event, Pharmacokinetic aspects, Liver, Adverse Event, Disease, Liver, Adverse Event, Drug-related disorder, Liver, Adverse Event, Disease, Other, Liver, Adverse Event, Alcohol consumption, Liver, Adverse Event, Imaging of liver, Liver, Adverse Event, Biopsy of liver
Item-grupper: Date of visit, Pharmacogenetic Test, Informed Consent, Pharmacogenetic Test, Informed Consent, Withdraw
Item-grupp: Pharmacokinetic aspects, Blood, Repeat
Item-grupp: Pharmacokinetic aspects
Item-grupper: Experimental Drug, Compliance Behavior, Return, Experimental Drug, Compliance Behavior, Dispense
Item-grupp: Experimental Drug, Compliance Behavior, Dispense